about
Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia.Role of tissue inhibitor of metalloproteinases-1 in the development of autoimmune lymphoproliferation.Thrombin Cleavage of Osteopontin Modulates Its Activities in Human Cells In Vitro and Mouse Experimental Autoimmune Encephalomyelitis In Vivo.Osteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases.Extracellular proteasome-osteopontin circuit regulates cell migration with implications in multiple sclerosis.Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.In Vitro and In Vivo Therapeutic Evaluation of Camptothecin-Encapsulated β-Cyclodextrin Nanosponges in Prostate Cancer.Mutation of FAS, XIAP, and UNC13D genes in a patient with a complex lymphoproliferative phenotype.A mutation in caspase-9 decreases the expression of BAFFR and ICOS in patients with immunodeficiency and lymphoproliferation.Triggering of B7h by the ICOS modulates maturation and migration of monocyte-derived dendritic cells.IL-17 protects T cells from apoptosis and contributes to development of ALPS-like phenotypes.Osteopontin induces soluble urokinase-type plasminogen activator receptor production and release.The -346T polymorphism of the SH2D1A gene is a risk factor for development of autoimmunity/lymphoproliferation in males with defective Fas function.Serum levels of osteopontin are increased in SIRS and sepsis.A double blind randomized experimental study on the use of IgM-enriched polyclonal immunoglobulins in an animal model of pneumonia developing shock.Solid Lipid Nanoparticles Carrying Temozolomide for Melanoma Treatment. Preliminary In Vitro and In Vivo Studies.ICOS-Ligand Triggering Impairs Osteoclast Differentiation and Function In Vitro and In Vivo.Development and Characterization of Solid Lipid Nanoparticles Loaded with a Highly Active Doxorubicin Derivative.Enhanced cytotoxic effect of camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo on orthotopic xenograft tumors.B7h triggering inhibits the migration of tumor cell lines.Variations of the perforin gene in patients with multiple sclerosisSubcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitisImprovement in the Anti-Tumor Efficacy of Doxorubicin Nanosponges in In Vitro and in Mice Bearing Breast Tumor ModelsXXIV World Allergy Congress 2015: Seoul, Korea. 14-17 October 2015Nanoemulsions as Delivery Systems for Poly-Chemotherapy Aiming at Melanoma Treatment
P50
Q33433741-3E564FDD-BD5B-48DB-ABCD-0F3E00BFF19CQ34255132-2E47C2B9-F5E6-4ECA-9BE8-DFAC07103610Q37127970-429AFEFE-CC6E-4D82-BE4F-9117600F106AQ37549558-5A78BF83-B603-41EB-82B6-E15B16991E60Q37690125-C9D18A7C-5B7C-40D6-A095-D563BCBD088FQ37716786-E745E50F-840E-4194-A04D-1E2A1E96001CQ38764500-AC5B86D0-1925-4BCB-9E2B-C1897B463370Q40234394-49AED6B4-3636-480B-9941-F202252617B4Q41609169-15D2804D-E960-4505-822B-B6B2F8A4DEBAQ44752446-7B6D9037-1D42-42DF-9B90-AA1087FE7287Q45115236-FE9665E6-4D0B-459C-8500-A5A6B5CE6A34Q45914909-F7362DDC-81F1-42A0-A7F0-1C4D95614840Q46004533-0446E203-16EB-49D1-8227-708244786334Q46861953-30870521-E0EF-4E1F-9860-DD532C8A7D58Q47983287-AE063938-AC44-4018-95F5-E89E1B4E8A6DQ48175785-D5F2A1F0-E454-4A09-A7BB-6A435394D63EQ48261321-D3A804D5-5586-4AFB-A38D-429149440B3FQ49805176-288D3E73-30B9-4733-A4D7-9FF3B5BBA727Q52778675-03E6DC7A-2558-463D-9CE4-5311FE564970Q54360215-253F2B80-6952-4451-8F2F-8F3C3FC2E73EQ59543708-C7BECBF4-765A-48C9-8E36-36FC41AD1216Q87642588-68E378BC-08E1-4A8C-B980-D365BC3B14F1Q92635367-82E2D599-EDEF-4104-B94D-C0EF4AB64005Q93740619-CBDE922F-4E49-4A1B-B60D-EE342DDE4B72Q94592070-BEA5ED65-A9C2-47DD-8211-2CF3F7C175D9
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Elena Boggio
@ast
Elena Boggio
@en
Elena Boggio
@es
Elena Boggio
@nl
type
label
Elena Boggio
@ast
Elena Boggio
@en
Elena Boggio
@es
Elena Boggio
@nl
prefLabel
Elena Boggio
@ast
Elena Boggio
@en
Elena Boggio
@es
Elena Boggio
@nl
P106
P21
P31
P496
0000-0003-2700-3597